Abstract:Non-nucleic acid targets, consisting primarily of metal ions, organic small molecules and proteins. They act as important biomolecules or cell surface markers, supplying integrated and comprehensive bio-diagnostic information for the early diagnosis and treatment of diseases. Meanwhile, the analysis of non-nucleic acid targets also offers the foundation for individualized medicine and precision therapy. Therefore, a versatile platform for non-nucleic acid targets requires development. Clustered regularly interspaced short palindromic repeats-associated protein (CRISPR/Cas) systems is driving a revolution in medical diagnostics due to high base-resolution and isothermal signal amplification. Nevertheless, the majority of CRISPR/Cas settings reported currently are targeted for nucleic acids, leaving restricted usage to non-nucleic acid targets. This is owing to the lack of suitable signal recognition transduction elements for connecting CRISPR to non-nucleic acid targets. Functional nucleic acids (FNAs), comprising aptamers and nucleic acid enzymes, are of great concern to the biological and medical professions because of their specific target recognition and catalytic properties. As appropriate, functional recognition elements, FNAs can be integrated into CRISPR/Cas systems to exploit the powerful capabilities of both. This review emphasizes the technical tricks of integrating CRISPR/Cas systems and FNAs for non-nucleic acid targeting diagnostic applications. We first offer a general overview and the current state of research in diagnostics for CRISPR/Cas and FNAs, respectively, highlighting strengths and shortcomings. A categorical summary of non-nucleic acid-targeted diagnostics is provided, with a key emphasis on fundamental insights into the versatile non-nucleic acid-targeted diagnostic toolbox. We then review emerging diagnostic strategies based on CRISPR/Cas systems and FNAs that are fast, accurate and efficient in detecting non-nucleic acid targets. Finally, we identify the challenges that remain in this emerging field and look to the future of the field, expanding to the integration of nanomaterials, development of wearable devices and point-of-care testing.

CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets

Versatile Detection with CRISPR/Cas System from Applications to Challenges

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection

CRISPR-Cas13a system: A novel tool for molecular diagnostics

CRISPR Cas system: A strategic approach in detection of nucleic acids

[Application of CRISPR/Cas-based Biosensors for Detecting Nucleic Acid of Pathogens].

CRISPR/Cas Systems towards Next-Generation Biosensing

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

CRISPR-Cas target recognition for sensing viral and cancer biomarkers

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

CRISPR molecular detection techniques: Advances from single to multiple detection methods

Harnessing CRISPR/Cas Systems for DNA and RNA Detection: Principles, Techniques, and Challenges

Application Research Progress in Biosensing and Bioimaging Based on CRISPR-Cas System

CRISPR: The Frontier Technology of Next-Generation RNA Detection

CRISPR-Cas systems: From gene scissors to programmable biosensors

CRISPR/Cas‐Powered Biosensing

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

Integration of CRISPR/Cas with functional nucleic acids as versatile toolbox for non-nucleic acid target diagnostics: a review

Nucleic acid-assisted CRISPR-Cas systems for advanced biosensing and bioimaging